Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06758596 · ClinicalTrials.gov registry record · Early Phase 1
Research Investigating Drug Effects-2 (RiDE-2)
A Early Phase 1 study, sponsored by University of Illinois at Chicago.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 144
- Enrollment target
NCT06758596 is a Early Phase 1 study that has not yet begun recruiting, run by University of Illinois at Chicago. The registered enrollment target is 144 participants.
The verdict
NCT06758596, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Illinois at Chicago.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 144 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand how people's mood, behavior, and brains respond to different recreational drugs. We are also trying to understand why some people may feel differently or their brain may respond differently than other people after taking the same recreational drug.
Interventions
- DRUG THC
- DRUG Placebo Oral Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2031-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06758596
The ClinicalTrials.gov registry entry for NCT06758596 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which THC is the first listed.
NCT06758596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06758596 about?
NCT06758596 is a clinical study titled "Research Investigating Drug Effects-2 (RiDE-2)". The purpose of this study is to better understand how people's mood, behavior, and brains respond to different recreational drugs. We are also trying to understand why some people may feel differently or their brain may respond differently than other people after taking the same recreational drug.
What is the current status of trial NCT06758596?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 144 participants. The study started on 2026-07-15. Estimated completion is 2031-06.
What interventions are being tested in trial NCT06758596?
The interventions under investigation include: THC (DRUG), Placebo Oral Capsule (DRUG).
Who is sponsoring clinical trial NCT06758596?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.